RGEN
Price:
$142.58
Market Cap:
$7.99B
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test k...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1986-04-29
Stock Exchange
NASDAQ
Ticker
RGEN
According to Repligen Corporation’s latest financial reports and current stock price. The company's current ROE is -0.10%. This represents a change of 223.12% compared to the average of -0.03% of the last 4 quarters.
The mean historical ROE of Repligen Corporation over the last ten years is 29.51%. The current -0.10% ROE has changed -100.32% with respect to the historical average. Over the past ten years (40 quarters), RGEN's ROE was at its highest in in the December 2019 quarter at 61.68%. The ROE was at its lowest in in the December 2017 quarter at -38.65%.
Average
29.51%
Median
4.72%
Minimum
-106.74%
Maximum
366.44%
Discovering the peaks and valleys of Repligen Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 538.54%
Maximum Annual ROE = 366.44%
Minimum Annual Increase = -443.31%
Minimum Annual ROE = -106.74%
Year | ROE | Change |
---|---|---|
2023 | 2.11% | -95.49% |
2022 | 46.81% | 538.54% |
2021 | 7.33% | -91.95% |
2020 | 91.12% | -75.13% |
2019 | 366.44% | -443.31% |
2018 | -106.74% | 18.62% |
2017 | -89.99% | 361.15% |
2016 | -19.51% | -356.31% |
2015 | 7.61% | -175.37% |
2014 | -10.10% | -165.20% |
The current ROE of Repligen Corporation (RGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.75%
5-year avg
102.76%
10-year avg
29.51%
Repligen Corporation’s ROE is less than Intuitive Surgical, Inc. (15.59%), less than ResMed Inc. (23.22%), less than Merit Medical Systems, Inc. (9.51%), greater than ICU Medical, Inc. (-5.36%), less than The Cooper Companies, Inc. (4.64%), less than West Pharmaceutical Services, Inc. (18.35%), less than Becton, Dickinson and Company (5.15%), less than Hologic, Inc. (16.13%), less than Teleflex Incorporated (5.28%), less than Haemonetics Corporation (13.43%), greater than AngioDynamics, Inc. (-95.11%), less than AptarGroup, Inc. (14.01%), greater than Envista Holdings Corporation (-37.24%),
Company | ROE | Market cap |
---|---|---|
15.59% | $195.14B | |
23.22% | $35.79B | |
9.51% | $6.14B | |
-5.36% | $4.12B | |
4.64% | $20.07B | |
18.35% | $22.93B | |
5.15% | $64.75B | |
16.13% | $18.34B | |
5.28% | $8.90B | |
13.43% | $4.30B | |
-95.11% | $277.53M | |
14.01% | $11.41B | |
-37.24% | $3.70B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repligen Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Repligen Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Repligen Corporation's ROE?
How is the ROE calculated for Repligen Corporation (RGEN)?
What is the highest ROE for Repligen Corporation (RGEN)?
What is the 3-year average ROE for Repligen Corporation (RGEN)?
What is the 5-year average ROE for Repligen Corporation (RGEN)?
How does the current ROE for Repligen Corporation (RGEN) compare to its historical average?